Key Developments: Shougang Lanza (02553) is conducting a global offering of 40 million shares from May 26 to May 29. Virtual Mind (01520) announced that its Chengdu subsidiary plans to launch a gold commemorative series featuring internationally renowned sports IPs, including Spain's La Liga and England's Manchester United. Imotiontech (01274) reported that its "Aimostar" large model has officially passed the generative AI service filing. Life Health (02370) disclosed that a 24% stake in the company held by Life Real Estate may be sold. Zhongxian Intelligent Qijia Holdings (08395) entered into a supplementary agreement regarding a placing matter, with trading resuming on May 26. China Medical System (00867) announced that its innovative highly selective TYK2 inhibitor CMS-D001 has received drug clinical trial approval notices for ulcerative colitis and Crohn's disease indications. ISDN Holdings (01656) stated that IDI Dynamics launched its first high-speed laser marking machine for semiconductor chip packaging and testing. Sihuan Pharmaceutical (02005) reported that methanesulfonate safinamide has been approved for registration as an active pharmaceutical ingredient for marketed preparations. Guofuqianzi (00290) plans to acquire 11.89 million shares of Luffa AI Limited for $19.8 million and subscribe for 10 million shares for $20 million. Changfeng Pharmaceutical (02652) announced that the NMPA has accepted the marketing authorization application for tiotropium bromide inhalation powder. CanSino Biologics (06185) initiated Phase I/II clinical trials for PCV24 and completed enrollment of the first subject. Operational Performance: China Travel HK (00308) reported first-quarter revenue of HK$1.1 billion, up 13% year-over-year. Wasion Holdings (03393) stated that Weiyuan Energy secured new overseas business contracts totaling over RMB 1.6 billion. 160 Health (02656) reported that as of the end of April, the cumulative number of public medical institutions with operational cooperation reached 120, achieving steady business growth.